Hashimoto's Thyroiditis

What it is

Hashimoto's thyroiditis is an autoimmune thyroid disease and the most common cause of hypothyroidism in iodine-sufficient regions. It affects women about 7 to 10 times more often than men, and it causes gradual immune-mediated damage to the thyroid gland. Other names include autoimmune thyroiditis and chronic lymphocytic thyroiditis.

In Hashimoto's, the immune system mistakenly targets thyroid tissue, especially proteins such as thyroid peroxidase and thyroglobulin. Over time, this can reduce the gland's ability to make thyroid hormones, leading to subclinical hypothyroidism or overt hypothyroidism. Some people have a painless enlarged thyroid, called a goiter, while others develop a small or atrophic gland. A brief early phase of excess thyroid hormone release can occur when inflamed thyroid cells leak stored hormone, but persistent hyperthyroidism is not typical.

Common symptoms, when hypothyroidism develops, include fatigue, feeling cold, constipation, dry skin, weight gain, heavy or irregular periods, slowed thinking, low mood, and hair thinning. Symptoms can be mild or absent early on, so the condition is often found on blood tests before it causes obvious problems.

How it works

Hashimoto's develops from a mix of genetic susceptibility, immune dysregulation, and environmental triggers. The immune system produces antibodies, especially thyroid peroxidase antibodies (TPOAb) and sometimes thyroglobulin antibodies (TgAb), but antibodies are only part of the process. T cells and other immune pathways also contribute to inflammation and destruction of thyroid follicular cells.

As functioning thyroid tissue is lost, the gland makes less thyroxine (T4) and triiodothyronine (T3). The pituitary gland responds by raising thyroid-stimulating hormone (TSH) in an attempt to push the thyroid to work harder. This is why a high TSH is often the earliest lab clue.

A simplified pattern is:

Stage	Typical lab pattern	What it may mean
Euthyroid autoimmune thyroiditis	Normal TSH and free T4, antibodies positive	Autoimmunity is present, but hormone production is still adequate
Subclinical hypothyroidism	High TSH, normal free T4	Early thyroid failure
Overt hypothyroidism	High TSH, low free T4	Clear thyroid hormone deficiency
Transient hashitoxicosis	Low TSH, high thyroid hormones for a short period	Hormone leakage from inflamed thyroid tissue

Iodine status matters. In iodine-sufficient settings, Hashimoto's is a leading cause of hypothyroidism. In India, thyroid disorders are common, but causes can vary by region and iodine intake history, so clinicians interpret thyroid tests in the local context rather than assuming one cause in every patient.

Diagnosis / how it's measured

Diagnosis is based on a combination of symptoms, examination, blood tests, and sometimes ultrasound.

The main tests are:

1. TSH: usually elevated when the thyroid is underactive.
2. Free T4: low in overt hypothyroidism, often normal in subclinical disease.
3. TPO antibodies: positive in most people with Hashimoto's.
4. Thyroglobulin antibodies: may support the diagnosis in some cases.

Ultrasound is not always required, but it can show a thyroid with a heterogeneous, hypoechoic appearance typical of autoimmune inflammation. Imaging is more useful when there is a goiter, a thyroid nodule, asymmetry, or uncertainty about the diagnosis.

A positive antibody test alone does not always mean a person needs treatment. Some people have thyroid antibodies for years with normal thyroid hormone levels. What matters most for treatment decisions is whether thyroid function is normal, mildly impaired, or clearly low.

Clinicians may also look for related autoimmune conditions, because Hashimoto's can occur along with disorders such as type 1 diabetes, celiac disease, pernicious anemia, vitiligo, or other autoimmune endocrine disease.

Evidence and uses

The main evidence-based treatment is levothyroxine, a synthetic form of T4, when hypothyroidism is present. It replaces the hormone the thyroid can no longer make adequately. The goal is to normalize TSH and free T4 and improve symptoms.

Treatment is usually recommended for overt hypothyroidism. For subclinical hypothyroidism, the decision is more individualized and may depend on the TSH level, symptoms, pregnancy status, infertility evaluation, goiter, antibody positivity, cardiovascular risk, and age. Mayo Clinic notes that after starting or changing levothyroxine, TSH is commonly rechecked in about 6 to 10 weeks, because dose effects take time to stabilize.

Important management points include:

Situation	Usual approach
Overt hypothyroidism	Levothyroxine is standard treatment
Subclinical hypothyroidism	Monitor or treat depending on TSH, symptoms, pregnancy, and risk factors
Pregnancy or trying to conceive	Lower threshold for treatment and closer monitoring
Positive antibodies but normal thyroid function	Usually monitoring, not automatic treatment

There is ongoing interest in diet, selenium, vitamin D, gluten-free diets, and other adjuncts. Evidence is mixed. Some studies show changes in antibody levels with certain supplements, but lower antibodies do not always translate into better symptoms or better long-term thyroid function. No supplement should replace standard treatment for hypothyroidism.

When to see a clinician

See a clinician if you have symptoms of hypothyroidism, a neck swelling, infertility concerns, menstrual changes, or a strong family history of thyroid or autoimmune disease. Testing is also reasonable if routine blood work shows a high TSH.

Seek prompt medical review if you are pregnant, planning pregnancy, or recently postpartum, because untreated hypothyroidism can affect both parent and fetus. Children and adolescents with poor growth, delayed puberty, or school performance changes also need evaluation.

If you are already taking levothyroxine, follow-up matters. Too little treatment can leave symptoms uncontrolled, while too much can cause palpitations, tremor, bone loss risk, or atrial fibrillation, especially in older adults.

Limitations and open questions

Hashimoto's is common, but it is not always straightforward. Symptoms such as fatigue, weight change, and brain fog are nonspecific and may persist even when thyroid blood tests are normal, so not every symptom in a person with antibodies is caused by the thyroid.

Antibody levels can help support diagnosis, but they are imperfect markers of disease activity. Ultrasound findings also overlap with other thyroid conditions. This is why diagnosis and treatment rely on the full clinical picture, not a single test.

Evidence for nonstandard therapies remains limited. Research continues on why some people progress quickly to hypothyroidism while others remain stable for years, why some patients have persistent symptoms despite normal TSH, and whether any nutritional or immune-targeted strategies can change long-term outcomes. For now, the strongest evidence supports careful diagnosis, periodic monitoring, and levothyroxine when thyroid hormone deficiency is present.